Semaglutide and tirzepatide can cause nausea, diarrhea, vomiting, constipation, abdominal (stomach) discomfort and pain, injection site reactions, fatigue, hypersensitivity (allergic) reactions (typically fever and rash), burping, hair loss and gastroesophageal reflux disease
For example, conditions like irritable bowel syndrome (IBS) are about twice as common in women as in men
These improvements may include: Lower blood pressure Reduced blood sugar and cholesterol levels Healthier weight Semaglutide injection helps individuals achieve and maintain weight loss by controlling blood sugar levels and regulating appetite, which can contribute to better heart health
Doctors can help address specific concerns and provide advice on the best ways to manage symptoms
So, we cant say for sure what percentage of women taking them are likely to become pregnant in a certain timeframe